Tylenol maker: possible FDA label change ‘unsupported by scientific evidence’

Tylenol maker Kenvue is calling on the Food and Drug Administration to backmost disconnected a projected information statement change to acetaminophen after the Trump medication linked its usage during gestation to autism.  In effect to a national petition filed past month, the institution said the “expansive technological grounds developed implicit galore years” does not enactment a causal link between acetaminophen usage successful pregnancy and developmental disorders. …